Transforming growth factor-β1 and interleukin-1β stimulate LDL receptor activity in HepG2 cells - Morby,C.D.; Gherardi,E.; Dovey,L.; Godliman,C.; Bowyer,D.E. (Atherosclerosis, 1992)